单孔腹腔镜子宫腺肌病病灶大部切除术临床应用

目的探讨单孔腹腔镜子宫腺肌病病灶大部切除术的可行性与安全性。 方法回顾性分析2018年3月至2020年6月在南京医科大学附属常州第二人民医院妇科接受单孔腹腔镜下子宫腺肌病病灶切除术＋子宫成形术的7例患者的临床资料并进行总结分析。 结果接受经脐单孔腹腔镜子宫腺肌病病灶大部切除术＋子宫成形术的7例患者手术均成功,术中未增加其他手术切口,无一例中转开腹手术。发生术中并发症的共2例,程度均较轻,术中及时给予相应处理,术后密切观察,恢复良好。所有患者术后恢复良好,均顺利出院,对切口愈合后的美容效果满意度高。出院后随访发现患者月经量明显减少,痛经症状明显改善,生存质量均显著提高。 结论严格把握手术适应证的情况下,单孔腹腔镜子宫腺肌病病灶大部切除术可能是安全、可行的。

Clinical report of single-site laparoendoscopic adenomyomectomy

ObjectiveTo explore the feasibility and safety of single-site laparoendoscopic adenomyomectomy. MethodsWe retrospectively reviewed the clinical data of 7 patients undergoing single-site laparoendoscopic adenomyomectomy combined with metroplasty in the department of Gynecology, the Affiliated Changzhou No.2 People′s Hospital of Nanjing Medical University from Mar.2018 to Jun.2020. ResultsAll the 7 cases of laparoendoscopic adenomyomectomy were successful, none of them were transferred to laparotomy, no other port incision was needed. The patients all recovered well and were plesaed with the esthetic effect . Follow-up after discharge showed that the patient′s menstrual volume was significantly reduced, dysmenorrhea symptoms were significantly improved, and the quality of life was significantly improved. ConclusionsUnder the indication range, single-site laparoendoscopic adenomyomectomy may be safe and feasible for appropriate patients.